Brief: Black Diamond Therapeutics Reports Qtrly Net Loss Per Share Of $0.97

Black Diamond Therapeutics

08/11/2021 14:21

Nov 8 (Reuters) - Black Diamond Therapeutics Inc  BDTX.O :
    * BLACK DIAMOND THERAPEUTICS REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * BLACK DIAMOND - CASH, CASH EQUIVALENTS, AND INVESTMENTS OF
$235.0 MILLION AS OF SEPT 30, 2021, EXPECTED TO BE SUFFICIENT TO
FUND OPERATIONS INTO H2 2023
    * QTRLY NET LOSS PER SHARE $0.97
    * Q3 EARNINGS PER SHARE VIEW $-0.98 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8hqzwB 
Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))